Stockreport

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

IGC Pharma, Inc.  (IGC) 
NASDAQ:AMEX Investor Relations: igcinc.us/investor-center/overview
PDF IGC-AD1 demonstrates the potential to modify tau and improve spatial memoryData supports the initiation of clinical trials investigating IGC-AD1 as a treatment for Alzhe [Read more]